EL HAJJI Sofia (@sofia_elhajji) 's Twitter Profile
EL HAJJI Sofia

@sofia_elhajji

MD-PhD student in liver research 🧬🔬. Surgery enthusiast 🏥. Empowering women in science 👩‍🔬. Sharing insights & discoveries in hepatology ✨

ID: 1810289053708976128

calendar_today08-07-2024 12:25:24

27 Tweet

12 Takipçi

57 Takip Edilen

Zhi Ven Fong, MD MPH DrPH (@zhivenfongmd) 's Twitter Profile Photo

“I do my Whipples through a 10 cm incision without a bookwalter” “I do my Whipples laparoscopically” “I do my Whipples robotically in 2 hours” Abu Dhabi: “Hold my beer” #ISW2024KualaLumpur

“I do my Whipples through a 10 cm incision without a bookwalter”

“I do my Whipples laparoscopically”

“I do my Whipples robotically in 2 hours” 

Abu Dhabi: “Hold my beer”

#ISW2024KualaLumpur
Transplant International (@transpl_int) 's Twitter Profile Photo

💡Takeaway: #TIPS can be a valuable tool in #HCC patients with portal hypertension waiting for transplantation, offering potential #tumour #control without compromising post-transplant outcomes rb.gy/fuyze0 6/7

💡Takeaway: #TIPS can be a valuable tool in #HCC patients with portal hypertension waiting for transplantation, offering potential #tumour #control without compromising post-transplant outcomes rb.gy/fuyze0 6/7
B Moeckli (@beatmoeckli) 's Twitter Profile Photo

Congratulations 🤝🩺✨ to Transplant International Chiara Becchetti Allaire Manon EL HAJJI Sofia for an insightful journal club on how to manage TIPS in HCC patients eligible for liver transplant buff.ly/4gJYmOG. What are your thoughts 👇 ?

Congratulations 🤝🩺✨ to <a href="/Transpl_Int/">Transplant International</a> <a href="/BecchettiChiara/">Chiara Becchetti</a> <a href="/allaire_manon/">Allaire Manon</a> <a href="/Sofia_Elhajji/">EL HAJJI Sofia</a> for an insightful journal club on how to manage TIPS in HCC patients eligible for liver transplant buff.ly/4gJYmOG. What are your thoughts 👇 ?
EL HAJJI Sofia (@sofia_elhajji) 's Twitter Profile Photo

Thank you for the opportunity you gave me to explain the process behind this work. It elicited insightful views on the topic. Let’s keep up with the questions to better the work #bavenoVIII

EASLnews (@easlnews) 's Twitter Profile Photo

🌟Join us at the EASL #LiverCancerSummit 2025! 📅 When: 20-22 February 2025 📍 Where: Paris & Online Are you ready to explore the cutting-edge science of liver cancer? This is the perfect opportunity to discover the latest advancements in liver cancer research, diagnosis, and

Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

Pathological response following neoadjuvant immune checkpoint inhibitors in HCC: a cross-trial, patient-level analysis The Lancet Oncology doi.org/10.1016/S1470-… 👉111 pts, 1.4 mo neoadj. 💊 👉MPR: 32%, PCR 18% 👉Best threshold 90% 🧐Neoadj ICI is the way to go ILCA EASL Education

Pathological response following neoadjuvant immune checkpoint inhibitors in HCC: a cross-trial, patient-level analysis
<a href="/TheLancetOncol/">The Lancet Oncology</a> 
doi.org/10.1016/S1470-…
👉111 pts, 1.4 mo neoadj. 💊
👉MPR: 32%, PCR 18%
👉Best threshold 90%
🧐Neoadj ICI is the way to go
<a href="/ILCAnews/">ILCA</a> <a href="/EASLedu/">EASL Education</a>
EL HAJJI Sofia (@sofia_elhajji) 's Twitter Profile Photo

Perioperative Tislelizumab + IMRT in Resectable HCC w/ Macrovascular Invasion ✅ Downstaging & high pathological response (66.7% MPR/pCR) 🕒 Improved RFS in surgical cases ⚠️ High PD rate -> unresectable cases—need for biomarkers & alt strategies rdcu.be/dYAPc

Perioperative Tislelizumab + IMRT in Resectable HCC w/ Macrovascular Invasion

✅ Downstaging &amp; high pathological response (66.7% MPR/pCR)
🕒 Improved RFS in surgical cases
⚠️ High PD rate -&gt; unresectable cases—need for biomarkers &amp; alt strategies

rdcu.be/dYAPc
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

Immunotherapy response induces divergent tertiary lymphoid structures in HCC Nature Immunology doi.org/10.1038/s41590… 👉 intratumoral TLS density⬆️after ICB -> MPR & RFS ⬆️ 👉CD20+CXCL13+ LAs surrogate for TLS ? 👉involuted TLS morphology after tumor regression 🥲exciting times for

Immunotherapy response induces divergent tertiary lymphoid structures in HCC
<a href="/NatImmunol/">Nature Immunology</a>
doi.org/10.1038/s41590… 
👉 intratumoral TLS density⬆️after ICB -&gt; MPR &amp; RFS ⬆️ 
👉CD20+CXCL13+ LAs surrogate for TLS ? 
👉involuted TLS morphology after tumor regression
🥲exciting times for
Journal of Hepatology (@jhepatology) 's Twitter Profile Photo

🆕EASL Clinical Practice Guidelines on the management of #hepatocellularcarcinoma❗️ ✅Updated advice for managing patients with #HCC & comprehensive review of pertinent data Full text👉bit.ly/3VKZmcy #CPGs #LiverTwitter EASLnews EASL Education Aleksander Krag

🆕EASL Clinical Practice Guidelines on the management of #hepatocellularcarcinoma❗️

✅Updated advice for managing patients with #HCC &amp; comprehensive review of pertinent data

Full text👉bit.ly/3VKZmcy

#CPGs
#LiverTwitter
<a href="/EASLnews/">EASLnews</a> 
<a href="/EASLedu/">EASL Education</a>
<a href="/AleksanderKrag/">Aleksander Krag</a>
Lukas Hartl (@hartl_md) 's Twitter Profile Photo

TIPS implantation not only leads to ⬇️ of portal pressure, but also ⬇️ systemic inflammation 🔥🧯 ⬇️ bacterial translocation 🦠 😃 IL-6 decrease independently linked to improved outcomes Fresh off the press: doi.org/10.1016/j.jhep…

TIPS implantation not only leads to ⬇️ of portal pressure, but also 

⬇️ systemic inflammation 🔥🧯
⬇️ bacterial translocation 🦠 
😃 IL-6 decrease independently linked to improved outcomes

Fresh off the press:
doi.org/10.1016/j.jhep…
Maasoumy_liverlab (@maasoumy_lab) 's Twitter Profile Photo

🆕 Treatment of refractory #ascites: TIPS, tunneled peritoneal catheter, or ascites pump? 🥇 TIPS: lowest incidence of complications 🦠 PeCa: peritonitis & device explantations 📈 👥 S. Schütte et al in Hepatology Communications 🔗bit.ly/42k8too #liverx #livertwitter

🆕 Treatment of refractory #ascites: TIPS, tunneled peritoneal catheter, or ascites pump?

🥇 TIPS: lowest incidence of complications
🦠 PeCa: peritonitis &amp; device explantations 📈

👥 S. Schütte et al in Hepatology Communications
🔗bit.ly/42k8too

#liverx #livertwitter
Gut Journal (@gut_bmj) 's Twitter Profile Photo

Brilliant #GUTVideo by Miyoshi & Alessandro Mannucci, MD et al entitled "Liquid biopsy to identify Barrett’s oesophagus, dysplasia and oesophageal adenocarcinoma: the EMERALD multicentre study" via bit.ly/4hCcdpF Paper via: bit.ly/3E2TDIY Ajay Goel Research Lab 暗之福音锅

Brilliant #GUTVideo by Miyoshi &amp; <a href="/AlexMannucci/">Alessandro Mannucci, MD</a> et al entitled

"Liquid biopsy to identify Barrett’s oesophagus, dysplasia and oesophageal adenocarcinoma: the EMERALD multicentre study" via

bit.ly/4hCcdpF

Paper via:

bit.ly/3E2TDIY

 <a href="/GoelLab/">Ajay Goel Research Lab</a> <a href="/gaofeng21cn/">暗之福音锅</a>
Transplant International (@transpl_int) 's Twitter Profile Photo

“Systematic Sex-Based Inequity in the MELD Score-Based Allocation System for Liver Transplantation in Germany” Read more here: bit.ly/3WQmpmK #gender #inequity #genderequity #liver #transplant #allocation #system ESOTtransplant Charité - Universitätsmedizin Berlin Eurotransplant

“Systematic Sex-Based Inequity in the MELD Score-Based Allocation System for Liver Transplantation in Germany”

Read more here: 
bit.ly/3WQmpmK

#gender #inequity #genderequity #liver #transplant #allocation #system
<a href="/ESOTtransplant/">ESOTtransplant</a> <a href="/ChariteBerlin/">Charité - Universitätsmedizin Berlin</a> <a href="/eurotransplant/">Eurotransplant</a>
UNIGE_en (@unige_en) 's Twitter Profile Photo

A study led by the UNIGE and the HUG has made a major breakthrough in the treatment of liver cancer. It shows that an interval of 50 days between stopping immunotherapy and liver transplantation significantly reduces the risk of rejection. unige.ch/medias/en/2025…

A study led by the UNIGE and the <a href="/hug_ge/">HUG</a> has made a major breakthrough in the treatment of liver cancer. It shows that an interval of 50 days between stopping immunotherapy and liver transplantation significantly reduces the risk of rejection. unige.ch/medias/en/2025…
HEPATOLOGY Journal (@hep_journal) 's Twitter Profile Photo

Original Article Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study Moeckli et al. #LiverX tinyurl.com/yrt77t4k

Original Article
Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study

Moeckli et al. 
#LiverX
tinyurl.com/yrt77t4k
JHEP Reports (@jhep_reports) 's Twitter Profile Photo

❗Hepatic IR and IGF1R signaling govern distinct metabolic and carcinogenic processes upon PTEN deficiency in the liver 🔓#OpenAccess at 👉 jhep-reports.eu/article/S2589-… #LiverTwitter #LiverDisease

❗Hepatic IR and IGF1R signaling govern distinct metabolic and carcinogenic processes upon PTEN deficiency in the liver

🔓#OpenAccess at 👉 jhep-reports.eu/article/S2589-…

#LiverTwitter
#LiverDisease
Cancers MDPI (@cancers_mdpi) 's Twitter Profile Photo

#OpenAccess 🔓 | ‘Call for Reading’ 📚#Immunotherapy and #Liver #Transplantation: A Narrative Review of Basic and Clinical Data 🔗mdpi.com/2072-6694/15/1… 👨‍🔬by Charles-Henri Wassmer, et al MDPI Cancers MDPI

#OpenAccess 🔓 | ‘Call for Reading’
📚#Immunotherapy and #Liver #Transplantation: A Narrative Review of Basic and Clinical Data
🔗mdpi.com/2072-6694/15/1…
👨‍🔬by Charles-Henri Wassmer, et al
<a href="/MDPIOpenAccess/">MDPI</a> <a href="/Cancers_MDPI/">Cancers MDPI</a>
HEPATOLOGY Journal (@hep_journal) 's Twitter Profile Photo

Original Article Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy. Scheiner et al. #LiverX tinyurl.com/5bdkdy6n

Original Article

Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy.

Scheiner et al.
#LiverX
tinyurl.com/5bdkdy6n